J. Lee

Persistence with solifenacin add‐on therapy in men with benign prostate obstruction and residual symptoms of overactive bladder after tamsulosin monotherapy

B. H. Chung, B. Chung, C. Kim, 2014, International journal of clinical practice.

A randomised, prospective double‐blind, propiverine‐controlled trial of imidafenacin in patients with overactive bladder

J. Park, Juryun Kim, J. Seo, 2014, International journal of clinical practice.

A randomised, double‐blind, parallel design, multi‐institutional, non‐inferiority phase IV trial of imidafenacin versus fesoterodine for overactive bladder

H. G. Kim, J. Kim, J. Seo, 2013, International journal of clinical practice.

Erratum to: The management of intra-abdominal infections from a global perspective: 2017 WSES guidelines for management of intra-abdominal infections

J. I. Kim, Ionut Negoi, K. Inaba, 2017, World Journal of Emergency Surgery.

Persistence of solifenacin therapy in patients with overactive bladder in the clinical setting: a prospective, multicenter, observational study

M. Choo, K-S. Lee, J. Lee, 2016, International journal of clinical practice.

Efficacy and safety of solifenacin succinate in Korean patients with overactive bladder: a randomised, prospective, double-blind, multicentre study

J. Paick, M. Choo, H. C. Jung, 2008, International journal of clinical practice.

Rate and associated factors of solifenacin add‐on after tamsulosin monotherapy in men with voiding and storage lower urinary tract symptoms

B. H. Chung, H. Lee, C. Kim, 2015, International journal of clinical practice.

Treatment satisfaction with low‐dose tamsulosin for symptomatic benign prostatic hyperplasia: results from a multicentre cross‐sectional survey

M. Oh, J. Kim, J. Bae, 2012, International journal of clinical practice.